Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umeclidinium/vilanterol NDPI in COPD (China, Phase 3)
CTR20130258Phase 3Completed
- Sponsor
- GSK
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Anoro Ellipta in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started May 2017; status: completed.
02
Drugs
Anoro Ellipta
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20130258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130258.